Returning for its seventh year, the Practical Radiation Oncology (PRO) Program continues to support the field with a two-day program specifically designed for the community practice radiation oncologist. This program takes place Saturday and Sunday to allow for doctors unable to leave their practice for a week to attend the premier scientific radiation oncology event. Program content is curated to address the needs of a community practice physician and will include disease site reviews, interactive case-based discussions, a coding update and a scientific overview. In addition to being available at a discounted rate as a weekend-only event, the PRO Program will also be included in the full registration package allowing all attendees access.
| Time | Event |
|---|---|
| 7:55 a.m. - 8:00 a.m. | PRO Program Welcome Speaker: Beant Gill, MD, Associates in Radiation Medicine |
| 8:00 a.m. - 9:15 a.m. | Session I – Advances in Breast Cancer Management: Early Stage Disease, Post-Neoadjuvant Radiation Therapy, and IMRT for Breast Cancer Treatment Moderator: Christine Chung, MD, H. Lee Moffitt Cancer Center Speakers: To Treat or Not To Treat: Patients with Early-stage Breast Cancer Janice Lyons, MD, University Hospitals Seidman Cancer Center and Case Western Reserve University Radiation Therapy for Breast Cancer Patients Treated with Neoadjuvant Chemotherapy Lisa Singer, MD, PhD, University of California, San Francisco Indications and Techniques for Breast IMRT Laura Warren, MD, Dana-Farber Cancer Institute Q&A |
| 9:30 a.m. - 10:45 a.m. | Session II – Brain Metastases Radiotherapy while Mitigating Radionecrosis and Neurotoxicity Moderators: Avani Rao, MD, Radiation Oncology Associates of the National Capital Region Beant Gill, MD, Associates in Radiation Medicine Speakers: Tailored Approach to Brain Metastases Management Stuart Burri, MD, Southeast Radiation Oncology Group Mitigating and Managing Neurotoxicity from Radiotherapy for Brain Metastases William Breen, MD, Mayo Clinic Prevention and Management Strategies for Radionecrosis Raj Singh, MD, The Ohio State University Wexner Medical Center Q&A |
| 11:00 a.m. - 12:15 p.m. | Session III – Business of Radiation Oncology for Clinicians Moderator: Bridget Koontz, MD, FASTRO, East Carolina University Speakers: Running a Private Practice Christopher Jahraus, MD, Generations Radiotherapy and Oncology PC How to Be a Partner with Your Business Manager Bridget Koontz, MD, FASTRO, East Carolina University How to Build a Business Plan Rebecca Swanson, MSHA, BSN, RN, OCN, AdventHealth Orlando What Academicians Need to Know about the Business of Radiation Oncology Kimberly Smith, MPA, Icahn School of Medicine at Mount Sinai Q&A |
| 12:15 p.m. - 1:00 p.m. | Break |
| 1:00 p.m. - 2:15 p.m. | Session IV – Benign Radiotherapy: Back To The Future Moderator: Simul Parikh, MD, Lake Huron Medical Center Speakers: LDRT for Osteoarthritis and Plantar Fasciitis Bobby Koneru, MD,FHN / Leonard Ferguson Cancer Center Pain, Pain, Go Away... LD-RT in Dupuytren's Contracture and Other Musculoskeletal Disorders Mudit Chowdhary, MD, Northside Hospital Benign CNS: Opportunities and State of the Art Jona Hattangadi-Gluth, MD, University of California, San Diego Q&A |
| 2:15 p.m. - 3:30 p.m. | Session V – Patient Guided Radiotherapy: Tools to Help Providers Support Patients When the "Right Choice" Isn't Always Clear Moderator: Joshua Jones, MD, Rochester Regional Health System Speakers: Goals of Care Conversations for the Radiation Oncologist Emily Martin, MD, University of California, Los Angeles Defining Radiotherapy Intent Joshua Jones, MD, Rochester Regional Health System Q&A |
| 3:45 p.m. - 5:00 p.m. | Session VI – Prevention and Management of Toxicity in Organs at Risk (OAR) Moderator: Christopher Pope, MD, CARTI, Little Rock Speakers: Lung OAR: Conventional Fractionated Treatment Julianna Bronk, MD, PhD, The University of Texas MD Anderson Cancer Center Lung OAR: Central and Ultracentral SBRT Matthew Ning, MD, MPH, MD Anderson Cancer Center Lung OAR: Perpherial Lung SBRT Shane Mesko, MD, MBA, University of California, Irvine Q&A |
| 5:00 p.m. - 6:15 p.m. | Session VII – Gynecologic Tumor Board – Case-Based Discussion of the Molecular and Treatment Approach Updates for the Management of Endometrial, Vulvar and Cervical Cancers Moderators: Elizabeth Kidd, MD, Stanford University Malolan Rajagopalan, MD, MBA, Mount Carmel Health System Speakers: Gynecologic Molecular Pathology Review for Endometrial, Vulvar and Cervix Cancers Taylor Jenkins, MD, Virginia Commonwealth University Endometrial Cancer Staging and Treatment Updates – The Significance of Pathology and Molecular Status Shari Damast, MD, Yale University Vulvar and Cervical Cancer Treatment Updates Junzo Chino, MD, Duke University Medical Center Q&A |
| Time | Event |
|---|---|
| 7:55 a.m. - 8:00 a.m. | PRO Program Welcome Speaker: Beant Gill, MD, Associates in Radiation Medicine |
| 8:00 a.m. - 9:15 a.m. | Session VIII – Implementation of a Prostate SBRT Program in the Community Setting Moderator: Sean Collins, MD, PhD, MedStar Georgetown University Hospital Speakers: Evidence that SBRT is a New Standard of Care for Localized Prostate Cancer Nicholas van As, MD, MB, The Royal Marsden Hospital Building a Successful Community Prostate SBRT Practice Jonathan Haas, MD, Perlmutter Cancer Center at New York University Langone Hospital How to Safely Deliver Prostate SBRT in a Community Setting Michael Zelefsky, MD, FASTRO, Perlmutter Cancer Center at New York University Langone Hospital Q&A |
| 1:00 p.m. - 2:15 p.m. | Session IX – Head and Neck Cancer - Prevention and Management of Radiation Therapy Toxicity Moderator: Virginia Diavolitsis, MD, Riverside Radiation Oncology Inc. Speakers: Reduction in Head and Neck Cancer Toxicity: Simulation and Planning Considerations Shauna Campbell, DO, Cleveland Clinic Management of Acute Toxicity from Head and Neck Radiation Therapy Carryn Anderson, MD, University of Iowa Hospitals and Clinics Treatment of Late Toxicity from Head and Neck Radiation Therapy Darrion Mitchell, MD, PhD, James Cancer Hospital, The Ohio State University Q&A |
| 2:15 p.m. - 3:30 p.m. | Session X – Introduction to Theranostics for the Community Radiation Oncologist Moderator: Arshin Sheybani, MD, UnityPoint Health Speakers: Radiopharmaceuticals for Prostate Cancer Jeff Michalski, MD, MBA, FASTRO, Washington University School of Medicine Delivering Radiopharmaceuticals within a Radiation Oncology Clinic Youssef Charara, PhD, Virginia Cancer Specialists Implementing a Multidisciplinary Theranostics Program in a Community Setting Brandon Mancini, MD, MBA, BAMF Health Q&A |
